Genenta Science
SAEN
4 hedge funds and large institutions have $3.67M invested in Genenta Science in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
2.13% more ownership
Funds ownership: 2.51% → 4.64% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$2M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11.9K |
Top Sellers
SAEN Hedge Fund Activity: Q4 2023 in Review
4 of the 6,877 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (SAEN) for Q4 2023, worth a combined $3.67M — up 60% from $2.29M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SAEN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Bank Julius Baer & Co, adding an estimated $2M.
- 4 institutional investors held Genenta Science (SAEN) as of Q4 2023, up from 3 in Q3 2023.
- Funds reported $3.67M of Genenta Science stock for Q4 2023, up 60% quarter-over-quarter.
- 1 fund opened new Genenta Science positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest Genenta Science buyer in Q4 2023 was Bank Julius Baer & Co, an estimated $2M added.
Based on aggregated 13F filings for Q4 2023.